The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis

BACKGROUND: DNA-based non-invasive prenatal testing (NIPT) using maternal blood constitutes an emerging technology for the detection of Down syndrome (DS). The aim of the study was to conduct a cost-effectiveness analysis to evaluate the economic costs and health implications of the introduction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayón, J. C., Orruño, E., Portillo, M. I., Asua, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397500/
https://www.ncbi.nlm.nih.gov/pubmed/30867656
http://dx.doi.org/10.1186/s12962-019-0173-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397500/
https://www.ncbi.nlm.nih.gov/pubmed/30867656
http://dx.doi.org/10.1186/s12962-019-0173-8

Ejemplares similares